{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:24:11Z","timestamp":1767677051372},"reference-count":7,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jcardioanesthesia.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1053\/j.jvca.2016.07.038","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T18:56:55Z","timestamp":1469818615000},"page":"e13-e14","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Synthetic Stimulant Reaching Epidemic Proportions: Flakka-induced ST-elevation Myocardial Infarction With Intracardiac Thrombi"],"prefix":"10.1053","volume":"31","author":[{"given":"Shane V.","family":"Cherry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiliam F.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2016.07.038_bib1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3109\/15563650.2013.847187","article-title":"Toxicity and death following recreational use of 2-pyrrolidino valerophenone","volume":"51","author":"Eiden","year":"2013","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1053\/j.jvca.2016.07.038_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijcard.2013.12.262","article-title":"Sudden death after sustained restraint following self-administration of the designer drug \u03b1-pyrrolidinovalerophenone","volume":"172","author":"Nagai","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.jvca.2016.07.038_bib3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/jat\/bkv011","article-title":"A fatal case of pentedrone and alpha-pyrrolidinovalerophenone poisoning","volume":"39","author":"Sykutera","year":"2015","journal-title":"J Anal Toxicol"},{"key":"10.1053\/j.jvca.2016.07.038_bib4","unstructured":"Ovalle D, Weaver J: South Florida\u2019s source for synthetic drugs: The China pipeline. Available at: \u3008http:\/\/www.miamiherald.com\/news\/local\/crime\/article35417625.html\u3009. Accessed July 7, 2016"},{"key":"10.1053\/j.jvca.2016.07.038_bib5","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1021\/acschemneuro.5b00160","article-title":"Structural modification of the designer stimulant \u03b1-pyrrolidinovalerophenone (\u03b1-PVP) influences potency at dopamine transporters","volume":"6","author":"Kolanos","year":"2015","journal-title":"ACS Chem Neurosci"},{"key":"10.1053\/j.jvca.2016.07.038_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuropharm.2014.02.016","article-title":"Pharmacology of novel synthetic stimulants structurally related to the \u201cbath salts\u201d constituent 3,4-methylenedioxypyrovalerone (MDPV)","volume":"87","author":"Marusich","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1053\/j.jvca.2016.07.038_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2131\/jts.39.1","article-title":"New recreational drug 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (alpha-PVP) activates central nervous system via dopaminergic neuron","volume":"39","author":"Kaizaki","year":"2014","journal-title":"J Toxicol Sci"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077016303020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077016303020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T01:00:01Z","timestamp":1536541201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077016303020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1053077016303020"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2016.07.038","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic Stimulant Reaching Epidemic Proportions: Flakka-induced ST-elevation Myocardial Infarction With Intracardiac Thrombi","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2016.07.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}